This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Kapil Saharia, Jay Fishman, Paige Porrett, , ,
Authors: Kapil Saharia, Jay Fishman, Paige Porrett, Stephanie Pouch, Wanessa Clemente
We will present the case of a patient with nonischemic cardiomyopathy who underwent heart transplantation from a genetically modified pig source animal and whose course was notable for detection of porcine CMV by plasma microbial cell-free DNA and xenograft failure.
Stephanie Pouch, MD, MS, FAST is an Associate Professor of Medicine and transplant infectious diseases physician at Emory University School of Medicine. Her clinical and research interests include multidrug-resistant bacterial infections in transplant recipients, as well as donor evaluation and donor-derived infections. She is active within the transplant community, serving as a Councilor in the TID Section of TTS, Co-Chair of the American Society of Transplantation Infectious Disease Community of Practice’s Donor Evaluation Working Group, and Vice Chair of the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee.
Kapil Saharia, MD, MPH is an Associate Professor of Medicine at University of Maryland School of Medicine and Section Chief of Solid Organ Transplant Infectious Diseases at University of Maryland Medical Center. He is the current Chair of the AST Infectious Diseases Community of Practice Safety/QI Working Group. His research interests include infectious disease outcomes research in solid organ transplant recipients and evaluation of novel diagnostic assays to improve the infectious disease management of solid organ transplant recipients.
Jay A. Fishman, M.D. is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman completed Internal Medicine and Infectious Disease training at MGH, and Fellowships in Molecular Biology and Genetics at Harvard Medical School. The Transplant Infectious Disease and Immunocompromised Host Program provides lifelong care for solid organ and stem cell transplant recipients and other immunocompromised hosts. With his background in immunology, virology and molecular biology, Dr. Fishman has defined the infectious risks in xenotransplantation, notably the role of porcine endogenous retrovirus and cytomegalovirus. He has over 300 peer-reviewed publications. He is Past-President of the American Society of Transplantation and Councilor of the International Xenotransplantation Association, Fellow of the American College of Physicians, American Society of Transplantation, and Infectious Disease Society of America.
Dr. Porrett is the Director for Clinical & Translational Research or the UAB Comprehensive Transplant Institute. She is also the inaugural director for vascularized composite allotransplantation (VGA) for the UAB CTI . Dr. Porrett has diverse intellectual interests and expertise. Her NIH-funded immunology laboratory studies maternal immune cell fate and function during pregnancy in both human and animal models. Recently, Dr. Porrett expanded her portfolio to include xenotransplantation and has published the world's first experience of a clinical-grade, geneedited porcine kidney transplant into a human being.
By viewing the material on this site you understand and accept that:
Transplant Infectious Disease
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6